why choose us

First received: July 14, 2022

Clinical Trial: A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Alzheimer's Disease

Study Type: INTERVENTIONAL


Official Title: A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)

Brief Summary: This is a randomized, double-blind, placebo-controlled first-in-human, Phase 1, safety, tolerability, pharmacokinetic (PK) and preliminary exploratory activity study of escalating multiple intravenous (IV) doses of IBC-Ab002 in persons with early Alzheimer's disease.The study will have both Single- and Multiple-Ascending Dose components.

Read more